Revolution Medicines develops targeted therapies for RAS-addicted cancers and uses LinkedIn for corporate communication.
4 reports, 4 independent
Updated Sep 17
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Revolution Medicines develops targeted therapies for RAS-addicted cancers and uses LinkedIn for corporate communication.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Revolution Medicines (United States)
company in Redwood City, United States
Nothing else this week.
-
Ras
Nothing else this week.
-
LinkedIn
American social networking website for people in professional occupations
Related events
Coverage
Newest first; wire copies grouped- fool.com
- themarketsdaily.com
- yahoo.comCan Revolution Medicines (RVMD) Justify Its Valuation On Daraxonrasib Survival Data?
- GlobeNewswireRevolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025 REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasda